The story of Viagra, and its developer copyright, presents a complex case study for investors. Originally a blockbuster drug, producing billions in sales , its intellectual property lapse created a wave of knock-off medications, significantly impacting its position . While certain firms may attempt to capitalize on similar conditions , the existing